| abstract |
MANDELIC HYDRAZIDES The present invention relates to new mandelic hydrazides of the formula (i), in which R ^ 1 ^ - R ^ 11 ^ have the meanings indicated in claim 1, are SGK inhibitors and can be used for the treatment of diseases and SGK-induced disorders, such as diabetes, obesity, metabolic syndrome (dyslipidemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, usually in fibrosis and inflammatory processes of any kind. |